Please log in to view this page
Username
Password
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....